In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes

Biochimica et Biophysica Acta - Biomembranes

Volumn 1768, Issue 10, 2007, Pages 2491-2499

  Hossann, Martin ^a   Wiggenhorn, Michael ^b   Schwerdt, Alenka ^b   Wachholz, Kirsten ^a   Teichert, Nicole ^a   Eibl, Hansjörg ^c   Issels, Rolf D ^a,d   Lindner, Lars H ^a,d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Content release rate; Doxorubicin; Hyperthermia; Phosphatidylglyceroglycerol; Poly(ethylene glycol); Thermosensitive liposomes

Indexed keywords

1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHOGLYCEROGLYCEROL; 1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLAMINE N [METHOXY(POLYETHYLENE GLYCOL) 2000]; CARBOXYFLUORESCEIN; DOXORUBICIN; GLYCEROL DERIVATIVE; GLYCEROPHOSPHOLIPID; LIPOSOME; MACROGOL 2000; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; HEAT SENSITIVITY; IN VITRO STUDY; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN STABILITY; SERUM; TRANSITION TEMPERATURE;

DOXORUBICIN; DRUG STABILITY; GLYCEROL; LIPID BILAYERS; LIPOSOMES; PALMITATES; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; SOLUBILITY; TEMPERATURE;

EID: 34948817174     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2007.05.021     Document Type: Article

References (40)

1. Bangham A.D., and Horne R.W. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J. Mol. Biol. 12 (1964) 660-668
2. Allen T.M., Hansen C., Martin F., Redemann C., and Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066 (1991) 29-36
3. Klibanov A.L., Maruyama K., Torchilin V.P., and Huang L. Amphipatic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268 (1990) 235-238
4. Blume G., and Cevc G. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim. Biophys. Acta 1146 (1993) 157-168
5. Allen C., Dos Santos N., Gallagher R., Chiu G.N., Shu Y., Li W.M., Johnstone S.A., Janoff A.S., Mayer L.D., Webb M.S., and Bally M.B. Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Biosci. Rep. 22 (2002) 225-250
6. O'Brien M.E., Wigler N., Inbar M., Rosso R., Grischke E., Santoro A., Catane R., Kieback D.G., Tomczak P., Ackland S.P., Orlandi F., Mellars L., Alland L., and Tendler C. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann. Oncol. 15 (2004) 440-449
7. Batist G., Barton J., Chaikin P., Swenson C., and Welles L. Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy. Expert Opin. Pharmacother. 3 (2002) 1739-1751
8. Walsh T.J., Finberg R.W., Arndt C., Hiemenz J., Schwartz C., Bodensteiner D., Pappas P., Seibel N., Greenberg R.N., Dummer S., Schuster M., and Holcenberg J.C. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N. Engl. J. Med. 340 (1999) 764-771
9. Judson I., Radford J.A., Harris M., Blay J.Y., van Hoesel Q., le Cesne A., van Oosterom A.T., Clemons M.J., Kamby C., Hermans C., Whittaker J., Donato di Paola E., Verweij J., and Nielsen S. Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur. J. Cancer 37 (2001) 870-877
10. Yatvin M.B., Weinstein J.N., Dennis W.H., and Blumenthal R. Design of liposomes for enhanced local release of drugs by hyperthermia. Science 202 (1978) 1290-1293
11. Chelvi T.P., and Ralhan R. Designing of thermosensitive liposomes from natural lipids for multimodality cancer therapy. Int. J. Hypertherm. 11 (1995) 685-695
12. Gaber M.H., Hong K., Huang S.K., and Papahadjopoulos D. Thermosensitive sterically stabilized liposomes: formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma. Pharm. Res. 12 (1995) 1407-1416
13. Needham D., and Dewhirst M.W. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv. Drug Delivery Rev. 53 (2001) 285-305
14. Lindner L.H., Eichhorn M.E., Eibl H., Teichert N., Schmitt-Sody M., Issels R.D., and Dellian M. Novel temperature-sensitive liposomes with prolonged circulation time. Clin. Cancer Res. 10 (2004) 2168-2178
15. Mills J.K., and Needham D. Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition. Biochim. Biophys. Acta 1716 (2005) 77-96
16. New R.R.C. Liposomes-A practical approach (1997), Oxford Univ. Press, Oxford
17. Papahadjopoulos D., Jacobson K., Nir S., and Isac T. Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. Biochim. Biophys. Acta 311 (1973) 330-348
18. Anyarambhatla G.R., and Needham D. Enhancement of the phase transition permeability of DPPC liposomes by incorporation of P-lyso-PC: a new temperature-sensitive liposome for use with mild hyperthermia. J. Liposome Res. 9 (1999) 491-506
19. Needham D., Anyarambhatla G., Kong G., and Dewhirst M.W. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res. 60 (2000) 1197-1201
20. Mabrey S., and Sturtevant J.M. Investigation of phase transitions of lipids and lipid mixtures by sensitivity differential scanning calorimetry. Proc. Natl. Acad. Sci. U. S. A. 73 (1976) 3862-3866
21. Hauck M.L., LaRue S.M., Petros W.P., Poulson J.M., Yu D., Spasojevic I., Pruitt A.F., Klein A., Case B., Thrall D.E., Needham D., and Dewhirst M.W. Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clin. Cancer Res. 12 (2006) 4004-4010
22. Weinstein J.N., Yoshikami S., Henkart P., Blumenthal R., and Hagins W.A. Liposome-cell interaction: transfer and intracellular release of a trapped fluorescent marker. Science 195 (1977) 489-492
23. Eibl H. Synthesis of glycerophospholipids. Chem. Phys. Lipids 26 (1980) 405-429
24. Lasic D.D. Preparation of liposomes. In: Lasic D.D. (Ed). Liposomes from physics to applications (1993), Elsevier Science, Amsterdam, The Netherlands 63-107
25. Mayer L.D., Bally M.B., Hope M.J., and Cullis P.R. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim. Biophys. Acta 816 (1985) 294-302
26. Dittmer J.C., and Lester R.L. A simple, specific spray for the detection of phospholipids on thin-layer chromatograms. J. Lipid Res. 15 (1964) 126-127
27. Eibl H., and Lands W.E. A new, sensitive determination of phosphate. Anal. Biochem. 30 (1969) 51-57
28. Galettis P., Boutagy J., and Ma D.D. Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia. Br. J. Cancer 70 (1994) 324-329
29. Allen T.M., and Cleland L.G. Serum-induced leakage of liposome contents. Biochim. Biophys. Acta 597 (1980) 418-426
30. Komatsu H., and Okada S. Increased permeability of phase-separated liposomal membranes with mixtures of ethanol-induced interdigitated and non-interdigitated structures. Biochim. Biophys. Acta 1237 (1995) 169-175
31. Webb M.S., Saxon D., Wong F.M., Lim H.J., Wang Z., Bally M.B., Choi L.S., Cullis P.R., and Mayer L.D. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. Biochim. Biophys. Acta 1372 (1998) 272-282
32. Kenworthy A.K., Hristova K., Needham D., and McIntosh T.J. Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). Biophys. J. 68 (1995) 1921-1936
33. Ickenstein L.M., Sandstrom M.C., Mayer L.D., and Edwards K. Effects of phospholipid hydrolysis on the aggregate structure in DPPC/DSPE-PEG2000 liposome preparations after gel to liquid crystalline phase transition. Biochim. Biophys. Acta 1758 (2006) 171-180
34. Nikolova A.N., and Jones M.N. Effect of grafted PEG-2000 on the size and permeability of vesicles. Biochim. Biophys. Acta 1304 (1996) 120-128
35. Nicholas A.R., Scott M.J., Kennedy N.I., and Jones M.N. Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles. Biochim. Biophys. Acta 1463 (2000) 167-178
36. Zuidam N.J., and Crommelin D.J. Chemical hydrolysis of phospholipids. J. Pharm. Sci. 84 (1995) 1113-1119
37. Mills J.K., and Needham D. The materials engineering of temperature-sensitive liposomes. Methods Enzymol. 387 (2004) 82-113
38. Chen Q., Tong S., Dewhirst M.W., and Yuan F. Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome. Mol. Cancer Ther. 3 (2004) 1311-1317
39. Maeda H., Wu J., Sawa T., Matsumura Y., and Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65 (2000) 271-284
40. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41 (2001) 189-207